scout
|Videos|November 15, 2022

Chemoimmunotherapy in mNSCLC: Design and Outcomes of the POSEIDON Trial

A key opinion leader reviews the study design and efficacy and safety outcomes of the POSEIDON trial investigating durvalumab + tremelimumab + chemotherapy for treatment of mNSCLC.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME